Lise Lotte Gluud
Lise Lotte Gluud
Gastrounit, Copenhagen University Hospital Hvidovre
Verified email at
Cited by
Cited by
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis
G Bjelakovic, D Nikolova, LL Gluud, RG Simonetti, C Gluud
Jama 297 (8), 842-857, 2007
Screening for breast cancer with mammography
PC Gøtzsche, KJ Jørgensen
Cochrane database of systematic reviews, 2013
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
L Wood, M Egger, LL Gluud, KF Schulz, P Jüni, DG Altman, C Gluud, ...
Bmj 336 (7644), 601-605, 2008
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses
LL Kjaergard, J Villumsen, C Gluud
Annals of internal medicine 135 (11), 982-989, 2001
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
HR Andersen, TT Nielsen, K Rasmussen, L Thuesen, H Kelbaek, ...
New England journal of medicine 349 (8), 733-742, 2003
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
G Bjelakovic, D Nikolova, LL Gluud, RG Simonetti, C Gluud
Cochrane database of systematic reviews, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials
J Savović, HE Jones, DG Altman, RJ Harris, P Jüni, J Pildal, B Als-Nielsen, ...
Annals of internal medicine 157 (6), 429-438, 2012
Vitamin D supplementation for prevention of mortality in adults
G Bjelakovic, LL Gluud, D Nikolova, K Whitfield, J Wetterslev, ...
Cochrane database of systematic reviews, 2014
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
T Vilsbøll, M Christensen, AE Junker, FK Knop, LL Gluud
Bmj 344, 2012
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
B Als-Nielsen, W Chen, C Gluud, LL Kjaergard
Jama 290 (7), 921-928, 2003
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
K Thorlund, PJ Devereaux, J Wetterslev, G Guyatt, JPA Ioannidis, ...
International journal of epidemiology 38 (1), 276-286, 2009
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
B Als-Nielsen, LL Gluud, C Gluud
Bmj 328 (7447), 1046, 2004
Bias in clinical intervention research
LL Gluud
American journal of epidemiology 163 (6), 493-501, 2006
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
LL Kjaergard, B Als-Nielsen
Bmj 325 (7358), 249, 2002
Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review
LL Kjaergard, J Liu, B Als-Nielsen, C Gluud
Jama 289 (2), 217-222, 2003
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
LL Gluud, K Christensen, E Christensen, A Krag
Hepatology 51 (2), 576-584, 2010
Cyclosporin versus tacrolimus for liver transplanted patients
E Haddad, V McAlister, E Renouf, R Malthaner, MS Kjaer, LL Gluud
Cochrane Database of systematic reviews, 2006
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
S Calanna, M Christensen, JJ Holst, B Laferrere, LL Gluud, T Vilsbøll, ...
Diabetologia 56 (5), 965-972, 2013
Branched‐chain amino acids for hepatic encephalopathy
B Als‐Nielsen, RL Koretz, LL Gluud, C Gluud
Cochrane Database of Systematic Reviews, 2003
The system can't perform the operation now. Try again later.
Articles 1–20